open access

Vol 50, No 6 (2016)
Review Article
Submitted: 2016-04-26
Get Citation

Cerebral vasomotor reactivity in neurodegenerative diseases

Łukasz Smoliński1, Anna Członkowska12
DOI: 10.1016/j.pjnns.2016.07.011
·
Neurol Neurochir Pol 2016;50(6):455-462.
Affiliations
  1. Second Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland
  2. Department of Clinical and Experimental Pharmacology, Medical University of Warsaw, Warsaw, Poland

open access

Vol 50, No 6 (2016)
Review articles
Submitted: 2016-04-26

Abstract

Small-caliber cerebral vessels change their diameters in response to alterations of key metabolite concentrations such as carbon dioxide or oxygen. This phenomenon, termed the cerebral vasomotor reactivity (CVMR), is the basis for blood flow regulation in the brain in accordance with its metabolic status. Typically, CVMR is determined as the amount of change in cerebral blood flow in response to a vasodilating stimulus, which can be measured by various neuroimaging methods or by transcranial Doppler. It has been shown that CVMR is impaired in cerebrovascular diseases, but there is also evidence of a similar dysfunction in neurodegenerative disorders. Here, we review studies that have investigated CVMR in the common neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. Moreover, we discuss potential neurodegenerative mechanisms responsible for the impairment of CVMR.

Abstract

Small-caliber cerebral vessels change their diameters in response to alterations of key metabolite concentrations such as carbon dioxide or oxygen. This phenomenon, termed the cerebral vasomotor reactivity (CVMR), is the basis for blood flow regulation in the brain in accordance with its metabolic status. Typically, CVMR is determined as the amount of change in cerebral blood flow in response to a vasodilating stimulus, which can be measured by various neuroimaging methods or by transcranial Doppler. It has been shown that CVMR is impaired in cerebrovascular diseases, but there is also evidence of a similar dysfunction in neurodegenerative disorders. Here, we review studies that have investigated CVMR in the common neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and multiple sclerosis. Moreover, we discuss potential neurodegenerative mechanisms responsible for the impairment of CVMR.

Get Citation

Keywords

Cerebral vasomotor reactivity, Alzheimer' s disease, Parkinson' s disease, Multiple sclerosis, Neurodegenerative disease

About this article
Title

Cerebral vasomotor reactivity in neurodegenerative diseases

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 50, No 6 (2016)

Article type

Review Article

Pages

455-462

Page views

417

Article views/downloads

574

DOI

10.1016/j.pjnns.2016.07.011

Bibliographic record

Neurol Neurochir Pol 2016;50(6):455-462.

Keywords

Cerebral vasomotor reactivity
Alzheimer's disease
Parkinson's disease
Multiple sclerosis
Neurodegenerative disease

Authors

Łukasz Smoliński
Anna Członkowska

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl